Health Canada inspection
Sanofi-Aventis Recherche & Developpement: Health Canada inspection of May 18, 2018
Health Canada · GMP · rating C
Key facts
| Establishment | Sanofi-Aventis Recherche & Developpement |
|---|---|
| City | Vitry-Sur-Seine |
| Province | Val-De-Marne |
| Country | France |
| Program | GMP |
| Start date | May 18, 2018 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.